Angela Hwang

Angela Hwang is a member of Pfizer’s Executive Team and Group President of the Pfizer Biopharmaceuticals Group. Her organisation of 26,000 colleagues across 125 countries is responsible for bringing over 600 innovative medicines and products to patients.

In 2020, more than 420 million people benefited from a Pfizer Biopharma medicine or vaccine to improve their health and, in some cases, save their lives. As Group President of Pfizer Biopharma, Angela leads 7 commercial business units, which strive to deliver transformational medicines that address major global health priorities. Angela has been with Pfizer for over 24 years, working across all geographies and therapeutic areas.

She is motivated by the common purpose that all Pfizer colleagues share: to bring breakthroughs to patients, regardless of where they are in the world. Her childhood as an Asian girl growing up in apartheid South Africa defined her worldview, and underscored the importance of equity in everything she does today. Angela is a strong advocate for women's leadership and sustainable global health equity, and she received the President’s Award from the 2021 National Diversity & Leadership Conference for her efforts to champion diversity, equity, and inclusion in her organization.

In 2019, she was named in Crain’s Notable Women in Healthcare list, and in 2020 she was ranked #16 in Fortune’s Top 50 Most Powerful Women. In 2021, she has been recognised as one of Modern Healthcare’s Top 25 Women Leaders, and as an A100 Honoree, which celebrates the 100 most impactful Asian American and Pacific Islander leaders of the past year. Having always been curious about transformation and the art of the possible, Angela launched Diverse Perspectives in 2019, a podcast series where she hosts global thought leaders pioneering change across a variety of industries.